TY - JOUR
T1 - Cancer cell migration and cancer drug screening in oxygen tension gradient chip
AU - Nam, Hyeono
AU - Funamoto, Kenichi
AU - Jeon, Jessie S.
N1 - Funding Information:
The authors would like to thank Seunggyu Kim for helpful discussion of selecting research topics. This work was supported by the Basic Science Research Program (2017R1D1A1B03030428) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education and by the KAI-NEET Institute of KAIST (N11200049). K.F. acknowledges JSPS KAKENHI (Grant No. 16H05906).
Publisher Copyright:
© 2020 Author(s).
PY - 2020/7/1
Y1 - 2020/7/1
N2 - Cancer metastasis, which is prevalent in malignant tumors, is present in a variety of cases depending on the primary tumor and metastatic site. The cancer metastasis is affected by various factors that surround and constitute a tumor microenvironment. One of the several factors, oxygen tension, can affect cancer cells and induce changes in many ways, including motility, directionality, and viability. In particular, the oxygen tension gradient is formed within a tumor cluster and oxygen is lower toward the center of the cluster from the perivascular area. The simple and efficient designing of the tumor microenvironment using microfluidic devices enables the simplified and robust platform of the complex in vivo microenvironment while observing a clear cause-and-effect between the properties of cancer cells under oxygen tension. Here, a microfluidic device with five channels including a gel channel, media channels, and gas channels is designed. MDA-MB-231cells are seeded in the microfluidic device with hydrogel to simulate their three-dimensional movement in the body. The motility and directionality of the cancer cells under the normoxic and oxygen tension gradient conditions are compared. Also, the viability of the cancer cells is analyzed for each condition when anticancer drugs are applied. Unlike the normoxic condition, under the oxygen tension gradient, cancer cells showed directionality toward higher oxygen tension and decreased viability against the certain anticancer drug. The simplified design of the tumor microenvironment through microfluidic devices enables comprehension of the response of cancer cells to varying oxygen tensions and cancer drugs in the hypoxic tumor microenvironment.
AB - Cancer metastasis, which is prevalent in malignant tumors, is present in a variety of cases depending on the primary tumor and metastatic site. The cancer metastasis is affected by various factors that surround and constitute a tumor microenvironment. One of the several factors, oxygen tension, can affect cancer cells and induce changes in many ways, including motility, directionality, and viability. In particular, the oxygen tension gradient is formed within a tumor cluster and oxygen is lower toward the center of the cluster from the perivascular area. The simple and efficient designing of the tumor microenvironment using microfluidic devices enables the simplified and robust platform of the complex in vivo microenvironment while observing a clear cause-and-effect between the properties of cancer cells under oxygen tension. Here, a microfluidic device with five channels including a gel channel, media channels, and gas channels is designed. MDA-MB-231cells are seeded in the microfluidic device with hydrogel to simulate their three-dimensional movement in the body. The motility and directionality of the cancer cells under the normoxic and oxygen tension gradient conditions are compared. Also, the viability of the cancer cells is analyzed for each condition when anticancer drugs are applied. Unlike the normoxic condition, under the oxygen tension gradient, cancer cells showed directionality toward higher oxygen tension and decreased viability against the certain anticancer drug. The simplified design of the tumor microenvironment through microfluidic devices enables comprehension of the response of cancer cells to varying oxygen tensions and cancer drugs in the hypoxic tumor microenvironment.
UR - http://www.scopus.com/inward/record.url?scp=85092431887&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85092431887&partnerID=8YFLogxK
U2 - 10.1063/5.0011216
DO - 10.1063/5.0011216
M3 - Article
AN - SCOPUS:85092431887
SN - 1932-1058
VL - 14
JO - Biomicrofluidics
JF - Biomicrofluidics
IS - 4
M1 - 11216
ER -